Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. KFY
5. ABBV
6. MU
7. DPZ
8. NAVN
9. DFTX
10. NVEC

Go back to Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update

Catyalyst Pharmaceutical (CPRX) Posts Q1 Loss of 7c/Share

May 16, 2014 8:04 AM EDT

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).

2014 Business Achievements To Date:

Completed enrollment of pivotal phase 3 trial of Firdapse in patients with LEMSRaised $26.8 million, net of expenses, in a public offering... More